AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Topical Absorbable Hemostats: Medical Devices Pipeline Assessment, 2019 - ResearchAndMarkets.com

January 10, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Jan 10, 2020--

The “Topical Absorbable Hemostats - Medical Devices Pipeline Assessment, 2019” report has been added to ResearchAndMarkets.com’s offering.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Topical Absorbable Hemostats pipeline products.

Scope

Reasons to buy

Key Topics Covered:

1 Introduction

1.1 Topical Absorbable Hemostats Overview

2 Products under Development

2.1 Topical Absorbable Hemostats - Pipeline Products by Stage of Development

2.2 Topical Absorbable Hemostats - Pipeline Products by Segment

2.3 Topical Absorbable Hemostats - Pipeline Products by Territory

2.4 Topical Absorbable Hemostats - Pipeline Products by Regulatory Path

2.5 Topical Absorbable Hemostats - Pipeline Products by Estimated Approval Date

2.6 Topical Absorbable Hemostats - Ongoing Clinical Trials

3 Topical Absorbable Hemostats - Pipeline Products under Development by Companies

3.1 Topical Absorbable Hemostats Companies - Pipeline Products by Stage of Development

3.2 Topical Absorbable Hemostats - Pipeline Products by Stage of Development

4 Topical Absorbable Hemostats Companies and Product Overview

4.1 3-D Matrix Ltd Company Overview

4.2 Angiotech Pharmaceuticals Inc Company Overview

4.3 Anika Therapeutics Inc Company Overview

4.4 APRUS Bio-Medical Innovations Pvt Ltd Company Overview

4.5 Arch Therapeutics Inc Company Overview

4.6 Baxter Healthcare Corp Company Overview

4.7 Baxter International Inc Company Overview

4.8 Beth Israel Deaconess Medical Center Inc Company Overview

4.9 Biomedica Management Corp Company Overview

4.10 Biom’Up SAS Company Overview

4.11 C. R. Bard Inc Company Overview

4.12 Cellphire Inc Company Overview

4.13 Ceramicos Para Aplicacoes Medicas SA Company Overview

4.14 Columbia University Company Overview

4.15 Covalent Medical, Inc. (Inactive) Company Overview

4.16 Covalon Technologies Ltd Company Overview

4.17 Cresilon Inc Company Overview

4.18 CryoLife Inc Company Overview

4.19 Endomedix Incorporated Company Overview

4.20 Entegrion Inc Company Overview

4.21 Ethicon US LLC Company Overview

4.22 ETX Pharma Inc Company Overview

4.23 Gamma Therapeutics Inc Company Overview

4.24 GATT Technologies BV Company Overview

4.25 gel-e Inc Company Overview

4.26 Haemostatix Ltd Company Overview

4.27 Hemostasis LLC Company Overview

4.28 HLL Lifecare Ltd Company Overview

4.29 Keratin Biosciences Inc Company Overview

4.30 Leader Biomedical Europe BV Company Overview

4.31 LifeBond Ltd Company Overview

4.32 Protege Biomedical Company Overview

4.33 Resorba GmbH Company Overview

4.34 Rice University Company Overview

4.35 Sanara MedTech Inc Company Overview

4.36 Sanofi Biosurgery Inc Company Overview

4.37 Sea Run Holdings Inc Company Overview

4.38 St Teresa Medical Inc Company Overview

4.39 Tectum Company Overview

4.40 The Medicines Company Company Overview

4.41 Therus Corporation Company Overview

4.42 Thrombotargets Corp Company Overview

4.43 United Health Products, Inc. Company Overview

4.44 University of Grenoble Alpes Company Overview

4.45 Virginia Commonwealth University Company Overview

4.46 Xcede Technologies Inc Company Overview

5 Topical Absorbable Hemostats- Recent Developments

5.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019

5.2 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships

5.3 Nov 05, 2019: Stryker signs agreement to acquire Wright Medical for $5.4bn

5.4 Oct 31, 2019: gel-e announces breakthrough status designation from the U.S. Food and Drug Administration (FDA) for its first internal-use flowable device

5.5 Oct 31, 2019: Sanofi Q3 well on track

5.6 Oct 30, 2019: The Medicines Company reports third-quarter 2019 financial results and achievement of major milestones for inclisiran

5.7 Oct 30, 2019: CryoLife reports third quarter 2019 financial results

5.8 Oct 30, 2019: Merit Medical reports earnings for third quarter of 2019

5.9 Oct 24, 2019: Baxter reports preliminary third quarter 2019 operating results

5.10 Oct 24, 2019: Anika reports third quarter 2019 financial results

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/z4ugx2

View source version on businesswire.com:https://www.businesswire.com/news/home/20200110005280/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 01/10/2020 08:40 AM/DISC: 01/10/2020 08:40 AM

http://www.businesswire.com/news/home/20200110005280/en